Fri, 02nd Apr 2021 00:16
April 1 (Reuters) - British regulators on Thursday said they
have identified 30 cases of rare blood clot events after the use
of the AstraZeneca COVID-19 vaccine, 25 more than the agency
previously reported.
The Medicines and Healthcare products Regulatory Agency said
it had received no such reports of clotting events following use
of the vaccine made by BioNTech SE and Pfizer Inc
.
(Reporting By Peter Henderson and Julie Steenhuysen
Editing by Chris Reese)
(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.
PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly ...
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...
FTSE 100 up 0.5%, FTSE 250 adds 0.4% *
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...
Astrazeneca (AZN)